Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 217

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2

Open access
Reiterer, Moritz, Rajan, Mangala, Gómez-Banoy, Nicolás, Lau, Jennifer D., Gomez-Escobar, Luis G., Ma, Lunkun, Gilani, Ankit, Alvarez-Mulett, Sergio, Sholle, Evan T., Chandar, Vasuretha, Bram, Yaron, Hoffman, Katherine, Bhardwaj, Priya, Piloco, Phoebe, Rubio-Navarro, Alfonso, Uhl, Skyler, Carrau, Lucia, Houhgton, Sean, Redmond, David, Shukla, Alpana P., Goyal, Parag, Brown, Kristy A., tenOever, Benjamin R., Alonso, Laura C., Schwartz, Robert E., Schenck, Edward J., Safford, Monika M., Lo, James C. · 2021 · Cell Metabolism

Abstract

Summary Individuals infected with SARS-CoV-2 who also display hyperglycemia suffer from longer hospital stays, higher risk of developing acute respiratory distress syndrome (ARDS), and increased mortality. Nevertheless, the pathophysiological mechanism of hyperglycemia in COVID-19 remains poorly characterized. Here, we show that hyperglycemia is similarly prevalent among patients with ARDS independent of COVID-19 status. Yet, among patients with ARDS and COVID-19, insulin resistance is the prevalent cause of hyperglycemia, independent of glucocorticoid treatment, which is unlike patients with ARDS but without COVID-19, where pancreatic beta cell failure predominates. A screen of glucoregulatory hormones revealed lower levels of adiponectin in patients with COVID-19. Hamsters infected with SARS-CoV-2 demonstrated a strong antiviral gene expression program in the adipose tissue and diminished expression of adiponectin. Moreover, we show that SARS-CoV-2 can infect adipocytes. Together these data suggest that SARS-CoV-2 may trigger adipose tissue dysfunction to drive insulin resistance and adverse outcomes in acute COVID-19.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cmet.2021.09.009

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Cited by

See all 217

Metadata

Authors
Reiterer, M., Rajan, M., Gómez-Banoy, N., Lau, J. D., Gomez-Escobar, L. G., Ma, L., Gilani, A., Alvarez-Mulett, S., Sholle, E. T., Chandar, V., Bram, Y., Hoffman, K., Bhardwaj, P., Piloco, P., Rubio-Navarro, A., Uhl, S., Carrau, L., Houhgton, S., Redmond, D., Shukla, A. P., Goyal, P., Brown, K. A., tenOever, B. R., Alonso, L. C., Schwartz, R. E., Schenck, E. J., Safford, M. M., & Lo, J. C.
Venue
Cell Metabolism
Publisher
Elsevier BV
Published
2021-11
Volume
33
Issue
11
Pages
2174-2188.e5
ISSN
1550-4131 (ISSN-L)
OpenAlex
W3198971744
Cited by
217
References
15
FWCI
12.66
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2. https://app.cochat.ai/papers/10.1016/j.cmet.2021.09.009
The paper
Reiterer, M., Rajan, M., Gómez-Banoy, N., Lau, J. D., Gomez-Escobar, L. G., Ma, L., Gilani, A., Alvarez-Mulett, S., Sholle, E. T., Chandar, V., Bram, Y., Hoffman, K., Bhardwaj, P., Piloco, P., Rubio-Navarro, A., Uhl, S., Carrau, L., Houhgton, S., Redmond, D., . . . Lo, J. C. (2021). Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2. Cell Metabolism. https://doi.org/10.1016/j.cmet.2021.09.009

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.